Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy

Muscle And Peripheral Nerve Disease
Duchenne Muscular Dystrophy (DMD)

Results
Download

Study results

LPS WN40227 SPITFIRE Final Results November 2020 English (PDF, 0.7 MB)

LPS WN40227 SPITFIRE Final Results November 2020 German (PDF, 1.3 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy

Study results

LPS WN40227 SPITFIRE Final Results November 2020 English (PDF, 0.7 MB)

LPS WN40227 SPITFIRE Final Results November 2020 German (PDF, 1.3 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

External Site

Directly contact Roche for questions

Contact the hospital directly

You are about to leave ForPatients

Thank you

Request a call back

Find participating medical centers and current study status in each of them

Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy

For the latest version of this information please go to www.forpatients.roche.com